Literature DB >> 6758224

A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.

K E Dixon, R G Williams, T Pongsupat, U Pitaktong, P Phintuyothin.   

Abstract

Falciparum malaria in 104 Thai patients was treated with either Mefloquine or Fansidar and patients were examined for parasitaemia for the next 28 days. All but one of the 40 patients treated with Mefloquine were cured, but the cure rates for Fansidar were only 9 . 1% for the two-tablet regimen and 19 . 4% for the three-tablet regimen. Most failures were classified as RII. Serum sulpha levels indicated that the Fansidar was being absorbed. Immediate steps should be taken to eliminate this focus of resistance and to protect against further resistance to Fansidar by using it in combination with another effective anti-malarial and by vigorous vector control measures.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6758224     DOI: 10.1016/0035-9203(82)90238-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome.

Authors:  L M Slutsker; C O Khoromana; D Payne; C R Allen; J J Wirima; D L Heymann; L Patchen; R W Steketee
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand.

Authors:  Md Tauqeer Alam; Sumiti Vinayak; Kanungnit Congpuong; Chansuda Wongsrichanalai; Wichai Satimai; Laurence Slutsker; Ananias A Escalante; John W Barnwell; Venkatachalam Udhayakumar
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

3.  Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.

Authors:  L W Pang; N Limsomwong; P Singharaj; C J Canfield
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 4.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 5.  Malaria prophylaxis in travellers: the current position.

Authors:  D Stürchler
Journal:  Experientia       Date:  1984-12-15

6.  Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.

Authors:  D Botero; M Restrepo; A Montoya
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

7.  Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria.

Authors:  Quique Bassat; Oumou Maïga-Ascofaré; Jürgen May; Jerôme Clain; Ghyslain Mombo-Ngoma; Mirjam Groger; Ayôla A Adegnika; Jean-Claude Dejon Agobé; Abdoulaye Djimde; Johannes Mischlinger; Michael Ramharter
Journal:  Malar J       Date:  2022-02-22       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.